ANIONA APS has a total of 16 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and China. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are TOPADUR PHARMA AG, SANOFI AVENTIS DEUTCHLAND GMBH and CHACKALAMANNIL SAMUEL.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 3 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Hong Kong | 1 | |
#6 | India | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Gustafsson Magnus | 8 |
#2 | Larsen Janus Schreiber | 8 |
#3 | Jessen Carsten | 8 |
#4 | Hougaard Charlotte | 3 |
#5 | Peters Dan | 3 |
#6 | Eriksen Birgitte L | 3 |
#7 | Teuber Lene | 2 |
#8 | Sorensen Ulrik Svane | 2 |
#9 | Munro Gordon | 2 |
#10 | Nielsen Karin Sandager | 2 |
Publication | Filing date | Title |
---|---|---|
WO2014001278A1 | A phenyl triazole derivative and its use for modulating the gabaa receptor complex | |
WO2014001280A1 | A phenyl triazole derivative and its use for modulating the gabaa receptor complex | |
WO2014001279A1 | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |